Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels
被引:11
作者:
Ahl, J
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Ahl, J
[1
]
Kinon, BJ
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Kinon, BJ
[1
]
Liu-Seifert, H
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
Liu-Seifert, H
[1
]
机构:
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
antipsychotics;
hyperprolactinemia;
neuroleptics;
prolactin;
risperidone;
sexual dysfunction;
D O I:
10.1196/annals.1314.041
中图分类号:
B84 [心理学];
C [社会科学总论];
Q98 [人类学];
学科分类号:
03 ;
0303 ;
030303 ;
04 ;
0402 ;
摘要:
We attempt to demonstrate the association between neuroleptic-induced hyperprolactinemia and sexual dysfunction in schizophrenic patients treated with prolactin-elevating antipsychotics. Our findings indicate that sexual function improved with euprolactinemia in patients switched from treatment with prolactin-elevating antipsychotics to olanzapine.